Skip to main content
. Author manuscript; available in PMC: 2013 Jul 26.
Published in final edited form as: J Clin Oncol. 2008 May 10;26(14):2292–2298. doi: 10.1200/JCO.2007.13.3165

Table 2.

Subsequent Vaccine and IL-2 Therapy in Courses 2 and 3

No. of Patients
Course of Treatment Trial 1
(n = 42)
Trial 2
(n = 40)
Trial 3
(n = 39)
Second course of vaccine 17 9 9
Second course of IL-2 17 7 4
Third course of vaccine 15 5 1
Third course of IL-2 8 3 0

NOTE. Number of patients receiving therapy in subsequent 12-week courses. Vaccine could be administered without IL-2.

Abbreviation: IL-2, interleukin-2.